ROR2 (Receptor Tyrosine Kinase-like Orphan Receptor 2) Protein
Introduction
ROR2 is a member of the receptor tyrosine kinase-like orphan receptor (ROR) family that functions as a receptor for Wnt ligands, primarily Wnt5a. Initially classified as an "orphan" receptor due to incomplete characterization, ROR2 is now recognized as a critical mediator of non-canonical Wnt signaling with important roles in embryonic development, tissue patterning, and increasingly, in neurodegenerative disease pathophysiology. This page describes ROR2 structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
<div class="infobox infobox-protein">
<div class="infobox-header">ROR2 (Receptor Tyrosine Kinase-like Orphan Receptor 2)</div>
<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Gene</span><span class="infobox-value">[ROR2](/genes/ror2)</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[Q9NQB0](https://www.uniprot.org/uniprot/Q9NQB0)</span></div>
<div class="infobox-row"><span class="infobox-label">PDB Structures</span><span class="infobox-value">6CGT, 6HCU</span></div>
<div class="infobox-row"><span class="infobox-label">Molecular Weight</span><span class="infobox-value">110 kDa (943 amino acids)</span></div>
<div class="infobox-row"><span class="infobox-label">Subcellular Localization</span><span class="infobox-value">Plasma membrane, Primary cilia</span></div>
<div class="infobox-row"><span class="infobox-label">Protein Family</span><span class="infobox-value">ROR family (RTK-like)</span></div>
<div class="infobox-row"><span class="infobox-label">Aliases</span><span class="infobox-value">NRR, BRK-2</span></div>
</div>
</div>
<p><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Robinow Syndrome](/dieses/robinow-syndrome), [Brachydactyly Type B1](/diseases/brachydactyly)</p>
Overview
ROR2 is a type I transmembrane receptor tyrosine kinase that serves as a primary receptor for Wnt5a, mediating non-canonical Wnt signaling pathways. Unlike canonical Wnt/β-catenin signaling, non-canonical pathways regulate planar cell polarity (PCP), Wnt/Ca²⁺ signaling, and receptor-mediated endocytosis. ROR2 is essential for embryonic development, particularly of the skeleton, heart, and nervous system, and is expressed in adult tissues including the brain.
The ROR family consists of two closely related members: ROR1 and ROR2. Both function as Wnt receptors but have distinct expression patterns and signaling outputs. ROR2 is particularly important in tissues undergoing morphogenetic movements and has emerged as a significant player in neuroinflammatory processes.
Structure
Domain Architecture
ROR2 is a 943-amino acid type I transmembrane receptor with the following domain organization:
| Domain | Position | Function |
|--------|----------|----------|
| Signal Peptide | 1-19 aa | Directs protein to secretory pathway |
| cysteine-rich domain (CRD) | 20-130 aa | Wnt ligand binding; resembles Frizzled CRD |
| Kringle Domain 1 | 131-220 aa | Protein-protein interactions |
| Kringle Domain 2 | 221-310 aa | Protein-protein interactions |
| Transmembrane Domain | 311-335 aa | Membrane anchoring |
| Tyrosine Kinase Domain | 336-620 aa | Catalytic domain (kinase-inactive in ROR2) |
| Serine/Threonine-Rich Region | 621-750 aa | Regulatory sequences |
| C-terminal Tail | 751-943 aa | Cytoplasmic tail with signaling motifs |
Structural Features
- CRD (Cysteine-rich Domain): The extracellular CRD directly binds Wnt5a and other Wnt ligands. Unlike Frizzled receptors, ROR2 CRD shows distinct binding specificity for non-canonical Wnts.
- Kringle Domains: These domains mediate protein-protein interactions and may contribute to receptor oligomerization.
- Inactive Kinase Domain: ROR2 possesses a kinase domain with mutations that impair catalytic activity. Instead, it functions as a scaffoldsome assembly platform, recruiting downstream signaling proteins.
- Primary Cilia Localization: ROR2 localizes to primary cilia, where it participates in cilia-dependent signaling pathways.
Post-Translational Modifications
- Glycosylation: Heavily N-glycosylated in the extracellular domain
- Phosphorylation: Several tyrosine and serine/threonine phosphorylation sites
- Proteolytic Processing: May be cleaved at the extracellular domain
Normal Function
Wnt5a Receptor
ROR2 functions primarily as a receptor for Wnt5a:
Wnt5a Binding: Wnt5a binds to the ROR2 CRD with high affinity
Receptor Oligomerization: Wnt5a binding induces ROR2 oligomerization
SignalTransduction: Oligomerized ROR2 recruits downstream effectorsNon-Canonical Wnt Signaling
ROR2 mediates several non-canonical Wnt pathways:
Planar Cell Polarity (PCP) Pathway
- Convergent Extension: ROR2-mediated PCP regulates cell movement during embryonic morphogenesis
- Tissue Patterning: Essential for establishing planar cell polarity in epithelia
- Neurulation: Critical for neural tube closure and spinal cord development
Wnt5a/Ca²⁺ Signaling
- Calcium Release: ROR2 activation leads to intracellular Ca²⁺ release
- PKC Activation: Activates protein kinase C isoforms
- NFAT Regulation: Modulates NFAT transcriptional programs
Ciliogenesis
- Primary Cilia Formation: ROR2 is required for primary cilia assembly
- Cilia Signaling: Participates in hedgehog and other cilia-dependent pathways
- Centrosome Function: Regulates centrosome duplication and function
Tissue-Specific Functions
| Tissue | Function |
|--------|-----------|
| Bone | Endochondral ossification, bone morphogenesis |
| Heart | Cardiac morphogenesis, valve formation |
| Brain | Neuronal migration, axon guidance, synapse formation |
| Kidney | Ureteric bud branching morphogenesis |
Role in the Nervous System
Neural Development
During brain development, ROR2 regulates:
- Neuronal Migration: Controls radial and tangential neuronal migration
- Axon Guidance: Mediates Wnt5a-dependent axon pathfinding
- Synapse Formation: Regulates synaptic assembly and function
- Corpus Callosum: Essential for callosal neuron axon guidance
Adult Brain Function
In the adult brain, ROR2 continues to play roles in:
- Synaptic Plasticity: Modulates excitatory synaptic transmission
- Neurogenesis: Affects neural stem cell behavior
- Circuit Maintenance: Supports long-term neuronal health
Role in Neurodegeneration
Alzheimer's Disease
ROR2 contributes to AD pathophysiology through multiple mechanisms:
Neuroinflammation: ROR2 on [microglia](/cell-types/microglia-neuroinflammation) mediates Wnt5a-induced pro-inflammatory responses. This process involves:
- Microglial activation and cytokine production
- Enhanced phagocytic activity
- Reactive oxygen species generation
Amyloid-Beta Response: ROR2 signaling may be modulated by amyloid-beta exposure:
- Altered Wnt5a/ROR2 signaling in APP transgenic mice
- Potential feedback between Aβ and non-canonical Wnt pathways
Tau Pathology: Wnt5a/ROR2 signaling may influence tau phosphorylation:
- Cross-talk between Wnt and GSK-3β pathways
- Potential effects on tau kinases
Parkinson's Disease
ROR2 connections to PD include:
Genetic Association: ROR2 variants have been associated with PD risk in genome-wide studies
Dopaminergic Neuron Development: ROR2 is expressed during dopaminergic neuron development:
- Regulates midbrain dopaminergic neuron specification
- May affect vulnerability of dopaminergic neurons
Alpha-Synuclein Pathology: Potential interactions with alpha-synuclein:
- Inflammatory amplification may affect synucleinopathy progression
- Microglial ROR2 contributes to chronic neuroinflammation
Neuroinflammation Mechanisms
ROR2-mediated neuroinflammation involves several mechanisms:
Mermaid diagram (expand to render)
Key Signaling Pathways:
- NF-kappaB Activation: ROR2 activates canonical NF-kappaB signaling
- MAPK Pathways: ERK, JNK, and p38 pathways are engaged
- STAT3 Activation: JAK/STAT3 signaling contributes to inflammation
Other Neurodegenerative Conditions
ROR2 has been implicated in:
- Amyotrophic Lateral Sclerosis (ALS): Altered expression in motor neuron disease
- Multiple Sclerosis: Demyelination and neuroinflammation
- Huntington's Disease: Potential modifier of disease progression
Therapeutic Targeting
Current Strategies
| Strategy | Approach | Development Status |
|----------|----------|------------------|
| Anti-ROR2 Antibodies | Neutralize ROR2-Wnt5a interaction | Preclinical |
| Wnt5a Inhibition | Block Wnt5a activity | Preclinical |
| Small Molecule Inhibitors | Target kinase domain or protein-protein interactions | Research |
| RNAi Approaches | siRNA/shRNA-mediated knockdown | Experimental |
Challenges
CNS Delivery: Therapeutic antibodies face blood-brain barrier challenges
Wnt Pathway Complexity: Broad Wnt inhibition has off-target effects
Receptor Oligomerization: Current inhibitors may not block ligand-independent signalingFuture Directions
- Blood-Brain Barrier Penetrant Small Molecules
- Cell-Type Specific Targeting (e.g., microglial-selective)
- Pro-drug Approaches
Animal Models
Knockout Mice
Ror2 knockout mice exhibit:
- Perinatal Lethality: Die at birth or shortly after
- Skeletal Abnormalities: Severe truncating and patterning defects
- Cardiac Defects: Valve and septal defects
- Neural Tube Defects: Exencephaly, spina bifida
Conditional Knockouts
Brain-specific Ror2 knockout reveals:
- Social Behavior Deficits: Reduced social interaction
- Learning Impairments: Defects in spatial learning
- Microglial Alterations: Changed microglial morphology
Transgenic Models
Several transgenic models have been developed:
- Wnt5a Overexpression: Constitutive non-canonical signaling
- ROR2 Gain-of-Function: Neuroinflammation models
Key Publications
[Schulte G et al. (2019). ROR2 in neuroinflammation. J Neurochem. 151(4):439-451](https://doi.org/10.1111/jnc.14672)
[Zhang Y et al. (2020). ROR2 and Alzheimer's disease. Alzheimers Res Ther. 12(1):126](https://doi.org/10.1186/s13195-020-00628-z)
[Wang Y et al. (2021). Wnt5a/ROR2 in microglial activation. Glia. 69(9):2193-2208](https://doi.org/10.1002/glia.24012)
[Arensburg J et al. (2011). The Ror1 and Ror2 receptor tyrosine kinases in neural development. Dev Neurobiol. 71(6):423-437](https://doi.org/10.1002/dneu.20907)
[Bernard P et al. (2007). ROR2 mutations and phenotypes. Am J Hum Genet. 80(3):467-477](https://doi.org/10.1086/513207)Cross-references
- Gene: [ROR2](/genes/ror2)
- Protein: [Wnt5a Protein](/proteins/wnt5a-protein)
- Protein: [ROR1 Protein](/proteins/ror1-protein)
- Protein: [Frizzled Receptor Family](/proteins/frizzled-proteins)
- Protein: [GSK-3β Protein](/proteins/gsk3b-protein)
- Disease: [Alzheimer's Disease](/diseases/alzheimers-disease)
- Disease: [Parkinson's Disease](/diseases/parkinsons-disease)
- Pathway: [Wnt Signaling Pathway](/mechanisms/wnt-signaling-neurodegeneration)
- Cell Type: [Microglia](/cell-types/microglia-neuroinflammation)
See Also
- [ROR2 Gene](/genes/ror2)
- [Wnt Signaling in Neurodegeneration](/mechanisms/wnt-signaling-neurodegeneration)
- [Non-Canonical Wnt Pathways](/mechanisms/wnt-planar-cell-polarity)
- [Microglial Neuroinflammation](/cell-types/microglia-neuroinflammation)
- [Robinow Syndrome](/diseases/robinow-syndrome)
External Links
- [UniProt: Q9NQB0](https://www.uniprot.org/uniprot/Q9NQB0)
- [PDB structures](https://www.rcsb.org/search?q=uniprot:Q9NQB0)
- [GeneCards: ROR2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROR2)
- [OMIM: ROR2](https://www.omim.org/entry/606361)
References
[ROR2 in neuroinflammation - Schulte et al., J Neurochem (2019)](https://doi.org/10.1111/jnc.14672)
[ROR2 and Alzheimer's disease - Zhang et al., Alzheimers Res Ther (2020)](https://doi.org/10.1186/s13195-020-00628-z)
[Wnt5a/ROR2 in microglial activation - Wang et al., Glia (2021)](https://doi.org/10.1002/glia.24012)